NK1 receptors are known to mediate inflammatory responses through the action of substance P. When activated, these receptors facilitate the release of pro-inflammatory cytokines, which contribute to the inflammatory cascade. This makes NK1 receptors a target for developing anti-inflammatory agents. In toxicological scenarios where inflammation is a consequence of exposure to a toxicant, modulation of NK1 receptor activity could potentially reduce tissue damage and improve outcomes.
